In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Holding AG

http://www.roche.com

Latest From Roche Holding AG

Biocon Biologics CEO Makes Surprise Exit

The CEO of Biocon’s biosimilars subsidiary has unexpectedly departed the role. Management stresses there is no disruption to its "strategic intent", but COVID-19 has "dampened" the arm’s push to reach its aspirational $1bn revenue target by 2022.

Commercial Biosimilars

Humanigen Takes Aim At IL-6 Inhibitors With CRS Drug Lenzilumab

Roche's Actemra is a major player in this space, but Humanigen is looking to take it on directly.

Research & Development Business Strategies

2020 Sees Sharp Rise In EU New Drug Approvals

The number of new drugs containing new active substances approved in the EU rose significantly in 2020, underpinned by a strong showing for orphan-designated products and a string of novel medicines for cancer and infectious diseases. Notable among the new clutch of approvals was the first ever COVID-19 vaccine, Pfizer/BioNTech's Comirnaty.

Europe Approvals

Breakthroughs, Orphans Hit High Notes As US FDA’s 2020 Novel Approvals Play A Familiar Tune

Influence of expedited review pathways and regulatory incentives is on display in 2020’s novel approvals, which have a composition reassuringly consistent with recent years.

Approvals Review Pathway
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Adheron Therapeutics
    • Anadys Pharmaceuticals, Inc.
    • Ariosa Diagnostics
    • Arius Research, Inc.
    • Boehringer Mannheim
    • CAPP Medical
    • Chugai Pharmaceutical Co., Ltd.
    • Dutalys GmbH
    • Flatiron Health
    • Foundation Medicine
    • Genentech Inc.
    • GeneWEAVE BioSciences, Inc.
    • Genia Technologies, Inc.
    • GlycArt Biotechnology
    • Hoffmann-La Roche
    • Inflazome Ltd.
    • Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
    • NexDx, Inc.)
    • Inception 5
    • InterMune, Inc.
    • Inflazome Ltd.
    • IQuum, Inc.
    • Jecure Therapeutics
    • Kapa Biosystems, Inc.
    • Marcadia Biotech, Inc.
    • Medingo Ltd.
    • Memory Pharmaceuticals Corporation
    • mtm laboratories AG
    • Piramed Pharma
    • Santaris Pharma A/S
    • Seragon Pharmaceuticals
    • Signature Diagnostics AG
    • Stratos Genomics
    • Syntex Corporation
    • Tanox, Inc.
    • Tensha Therapeutics, Trophos SA
    • Ventana Medical Systems, Inc.
    • Viewics, Inc.
UsernamePublicRestriction

Register